Regulated health AI · SaMD · diagnostics · medtech · digital health
Not because it's bad. Because no one has de-risked the buyer, the claims, the evidence, or the contract. That gap has a name: trust debt.
A small, application-only cohort that closes it, before you spend a year in market.
Built by Arvita Tripati. 30+ FDA-regulated, AI-enabled, and regulated health products shipped or scaled, including cardiac AI on the Apple Watch.
The meeting is not the milestone.
None of it means there's a buyer, a budget, or a deal that survives procurement. The lab tells you what the market needs to believe before you chase it.
Not product problems. Trust problems. Most companies hit them in this order.
Interest isn't demand. Polite meetings, encouraging advisors, no budget owner. Nothing moves.
The fan isn't the buyer. The person who loves it rarely controls the budget. Find who can sign.
Your proof doesn't travel. Home-market traction won't carry a US buyer, regulator, or investor. They want different evidence.
Claims aren't marketing. In regulated health they set your path, your evidence bar, and your risk. Broad claims cost you.
A pilot isn't a strategy. It only counts if the buyer, the metrics, and the next contract exist before it starts.
All five are fixable before you commit the year. That's the lab.
Each ends in something you can hand a US buyer, investor, or regulator. A package, not a certificate.
The segment with real pain, a budget, and a path to purchase.
Intended use, positioning, and the proof each claim demands.
What buyers, payers, and investors need to believe, and where your proof falls short.
The privacy, security, governance, and procurement questions a buyer will ask first.
Ownership, metrics, pricing, and the conversion criteria set up front.
The expansion story, pressure-tested the way an investor or partner will.
Four moves. In person, hybrid, or virtual. The work doesn't change.
Arvita Tripati, founder of Vahana Labs. Her whole career is the gap this lab closes: the distance between a product that works and a US contract that survives review.
30+ FDA-regulated, AI-enabled, and regulated health products shipped or scaled. Cardiac AI cleared on the Apple Watch. Clinical-trial tech run with Moderna, Gilead, the NHS, and Bristol-Myers Squibb. Three founding teams through Series A and B.
In the lab she's the operator connecting every thread, buyer to claims to evidence to investor story, and brings in named specialists where a cohort needs more depth.
Judge for MedTech Innovator and BioTools Innovator; mentor at Rutgers, Alchemist, Redesign Health, and Plug and Play. Background only; no endorsement implied.
Small, by application. It starts with a short fit call.
Not this quarter? Join the list: arvita@vahanalabs.ai